Wisconsin and five other states last week joined the Federal Trade Commission’s lawsuit to stop Amgen, one of the world’s largest pharmaceutical companies, from buying another drug company in a $28 billion deal.
To access this content, you must purchase a Premium membership, or log in if you are a member.